Perrigo Company PLC Receives Consensus Rating of “Buy” from Brokerages (NASDAQ:PRGO)
Perrigo Company PLC (NASDAQ:PRGO) has earned an average rating of “Buy” from the seventeen brokerages that are currently covering the stock, AnalystRatings.NET reports. Three equities research analysts have rated the stock with a hold recommendation and eleven have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $159.18.
Shares of Perrigo Company PLC (NASDAQ:PRGO) opened at 132.37 on Friday. Perrigo Company PLC has a 52-week low of $112.05 and a 52-week high of $168.39. The stock has a 50-day moving average of $144.1 and a 200-day moving average of $152.0. The company has a market cap of $17.711 billion and a P/E ratio of 72.65.
Perrigo Company PLC (NASDAQ:PRGO) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.51 by $0.20. The company had revenue of $1,000.00 million for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $1.42 earnings per share. The company’s revenue for the quarter was up 9.1% on a year-over-year basis. On average, analysts predict that Perrigo Company PLC will post $6.25 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, June 17th. Investors of record on Friday, May 30th will be paid a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date of this dividend is Wednesday, May 28th.
A number of analysts have recently weighed in on PRGO shares. Analysts at Argus cut their price target on shares of Perrigo Company PLC from $175.00 to $160.00 in a research note on Thursday. They now have a “buy” rating on the stock. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Perrigo Company PLC in a research note on Thursday. They now have a $180.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. cut their price target on shares of Perrigo Company PLC from $190.00 to $175.00 in a research note on Friday, May 9th.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.